Research

Cholesterol plays a decisive role in the elasticity of cell membranes. Researchers at FAU have now discovered that cholesterol has a remarkable double role: It not only contributes to making the membrane thicker and more impenetrable, but surprisingly also softer.

Prof. Aldo R. Boccaccini, Chair of Materials Science (Biomaterials), Department of Materials Science and Engineering at FAU, has been elected Fellow of Biomaterials Science and Engineering (FBSE), the highest honor the global biomaterials community can bestow on outstanding biomaterials scientists, ...

Two researchers have been awarded a Consolidator Grant from the European Research Council. The ERC Consolidator Grant entails two million euros in funding over a funding period of five years.

Once again, FAU has successfully demonstrated its strength in innovation and research. In the current funding round, the University has succeeded in winning not one, but two more Humboldt professorships: Prof. Dr. Michaela Mahlberg and Prof. Dr. Eva Pils.

This year, the Federal President’s prize for technology and innovation has been awarded to a team from Erlangen. Prof. Dr. Michael Uder and his two team colleagues from Siemens Healthineers have been awarded the German Future Prize 2023.

Malaria is one of the most widespread and deadly infectious diseases worldwide. New compounds are continuously required due to the risk of malaria parasites becoming resistant to the medicines currently used. A team of researchers at FAU led by Prof. Dr. Svetlana B. Tsogoeva has now combined the anti-malaria drug artemisinin with coumarin, which, like artemisinin, is also found in plants, and developed an auto-fluorescent compound from both bioactive substances.

Optical cavities allow the properties of quantum materials such as their electrical conductivity to be manipulated in a targeted manner. Physicists at FAU are investigating this enormous potential for electronics, energy storage and quantum computing. Their work has now received just under two million euros in funding from the Gordon and Betty Moore Foundation for the coming four years.

In the rare disease erythromelalgia, disorders in the smallest nerves and vessels in the skin lead to a painful, burning sensation. The temperature of the skin is increased and those affected by the disease suffer from swelling and redness in their feet, and more rarely also in their hands, arms, legs, ears and face. Until now there has been no effective treatment. The EASE study hopes to change that.